Enhance your knowledge with our comprehensive guide and curated study materials.
| Disease | Agent | Source / Reservoir | Transmission | Key Features | Public Health Importance |
|---|---|---|---|---|---|
| COVID-19 | SARS-CoV-2 | Humans (initial zoonotic origin) | Droplet + airborne ⭐ | Fever, cough, anosmia ⭐ | Global pandemic, high impact ⭐ |
| SARS | SARS-CoV | Bats → civet cats | Droplet | Severe pneumonia | High mortality, outbreak control importance |
| MERS | MERS-CoV | Camels | Droplet + contact | Severe respiratory disease | High case fatality ⭐ |
| Avian Influenza | Influenza A (H5N1, H7N9) | Birds ⭐ | Animal → human | Severe pneumonia | Pandemic potential ⭐ |
| Swine Flu (H1N1) | Influenza A (H1N1)pdm09 | Humans (origin swine) | Droplet | ILI, pneumonia | Pandemic (2009) ⭐ |
| Component | Key Elements |
|---|---|
| Surveillance ⭐ | Early detection, reporting, lab confirmation |
| Preparedness Planning ⭐ | National pandemic plans, guidelines |
| Healthcare System Readiness | ICU beds, oxygen, ventilators |
| Workforce Training | Trained healthcare workers |
| Infection Control ⭐ | PPE, mask use, hygiene protocols |
| Laboratory Capacity | RT-PCR, diagnostic facilities |
| Vaccination Strategy ⭐ | Vaccine development, distribution |
| Risk Communication ⭐ | Public awareness, misinformation control |
| Intersectoral Coordination | Government + health + transport sectors |
| Stockpiling ⭐ | Drugs (oseltamivir), PPE, equipment |
Detection of unusual cluster (ILI / SARI cases)
↓
Verification of outbreak ⭐
↓
Case definition formulation
↓
Active surveillance ⭐
Case finding
Contact tracing
↓
Laboratory confirmation ⭐
↓
Public health measures ⭐
Isolation of cases
Quarantine of contacts
Mask use & hygiene
↓
Clinical management ⭐
Supportive care
Antivirals (if available)
↓
Vaccination strategy (if available)
↓
Monitoring & containment ⭐



Key Exam Mapping ⭐
Vaccination
Mask use
Hand hygiene
Health education
Early diagnosis
Testing (RT-PCR)
Isolation
Treatment
ICU care
Rehabilitation
Emerging diseases → SARS, MERS, COVID, H1N1 ⭐
Pandemic preparedness → surveillance + vaccine + PPE ⭐
Outbreak response → detect → confirm → control ⭐
Prevention levels → Primary (prevent), Secondary (detect), Tertiary (treat) ⭐
Droplet transmission
Influenza, COVID-19
Airborne transmission
COVID-19 (closed spaces), measles
Contaminated food/water
Examples:
Hepatitis A, Rotavirus
Skin/mucosal contact
Examples:
Herpes, HPV
Transfusion, needle injury
Examples:
HIV, Hepatitis B, C
Through insects
Examples:
Dengue (Aedes mosquito), Japanese encephalitis
Mother → child
Examples:
HIV, Rubella ⭐
| Route | Examples |
|---|---|
| Respiratory | Influenza, COVID-19 ⭐ |
| Feco-oral | Hepatitis A, Rotavirus |
| Contact | Herpes, HPV |
| Blood-borne | HIV, Hepatitis B |
| Vector-borne | Dengue, JE |
| Vertical | HIV, Rubella ⭐ |
Protection of non-immune individuals when:
A large proportion of population is immune ⭐
Reduces transmission chain
Breaks spread of infection
Depends on:
Infectivity (R₀)
Example:
Measles → very high threshold (~95%) ⭐
Vaccinated population ↑
↓
Susceptible individuals ↓
↓
Transmission chain interrupted ⭐
↓
Disease spread controlled
Active immunity
Natural → infection
Artificial → vaccination ⭐
Prevent disease
Reduce severity
Achieve herd immunity
Herd immunity → community protection ⭐
Vaccination → main tool for control ⭐
Threshold depends on R₀ ⭐
Detection of unusual increase in cases
↓
Confirm outbreak (clinical + epidemiological) ⭐
↓
Define case definition
↓
Active surveillance ⭐
Case finding
Contact tracing
↓
Laboratory confirmation ⭐
↓
Control measures ⭐
Isolation
Quarantine
Vaccination (if available)
↓
Treatment & supportive care
↓
Monitoring & reporting ⭐
Separation of:
Infected individuals from healthy persons ⭐
Purpose:
Prevent transmission
Hospital isolation
Home isolation
Continuous systematic collection, analysis, and interpretation of data ⭐
Passive surveillance
Routine reporting
Active surveillance ⭐
Active case search
Sentinel surveillance
Selected sites
Data collection
↓
Data analysis
↓
Interpretation ⭐
↓
Action (control measures) ⭐
| Feature | Isolation | Surveillance |
|---|---|---|
| Definition | Separation of infected cases | Continuous monitoring of disease |
| Purpose | Prevent spread | Early detection & control ⭐ |
| Focus | Individual | Population |
| Example | COVID isolation ward | Influenza surveillance system |
Transmission → respiratory most important ⭐
Herd immunity → breaks transmission chain ⭐
Outbreak response → detect → confirm → control ⭐
Isolation → case separation ⭐
Surveillance → data → action cycle ⭐
Declared eradicated in:
1980 by WHO ⭐
Last natural case:
1977 (Somalia) ⭐
Strategy:
Surveillance + containment (ring vaccination) ⭐
Vaccine:
Live vaccinia virus
Importance:
First disease eradicated globally ⭐
| Feature | Smallpox | Chickenpox (Varicella) |
|---|---|---|
| Agent | Variola virus | Varicella-zoster virus |
| Rash distribution | Centrifugal (face, limbs) ⭐ | Centripetal (trunk) ⭐ |
| Lesion stage | Same stage ⭐ | Different stages ⭐ |
| Severity | Severe, high mortality | Mild |
| Palms/soles | Involved ⭐ | Usually spared |
Same virus causes:
Varicella (primary infection) ⭐
Herpes zoster (reactivation) ⭐
Latency:
Virus remains dormant in dorsal root ganglia ⭐
Very high (~90%) ⭐
Indicates:
Highly contagious disease
Pathognomonic sign ⭐
Appearance:
Bluish-white spots on buccal mucosa
Timing:
Before rash onset ⭐
1st dose:
9–12 months ⭐
2nd dose:
16–24 months ⭐
Purpose:
Ensure immunity in non-responders
Given as:
MR / MMR vaccine ⭐
Infection during:
1st trimester ⭐
Leads to:
Severe fetal abnormalities
Prevention:
Vaccination before pregnancy ⭐
Cataract
Congenital heart disease
Deafness ⭐
Microcephaly
Mental retardation
Growth retardation
Aseptic meningitis (~15%) ⭐
Orchitis (post-pubertal males)
Pancreatitis
Deafness (irreversible) ⭐
Components:
Measles + Mumps + Rubella ⭐
Type:
Live attenuated vaccine ⭐
Schedule:
2 doses (childhood)
Benefit:
Combined protection ⭐
Caused by:
Influenza A ⭐
Mechanism:
Antigenic shift ⭐
Examples:
H1N1 (2009) ⭐
Drift ⭐
Minor mutation
Causes epidemics
Shift ⭐
Major change
Causes pandemics
Only in Influenza A ⭐
Pandemic declared:
2009 ⭐
Virus:
Influenza A (H1N1)pdm09
Key feature:
Affects young adults
Drug:
Oseltamivir ⭐
Agent:
Influenza A (H5N1) ⭐
Transmission:
Bird → human ⭐
Feature:
Severe pneumonia
Importance:
Pandemic potential ⭐
Smallpox → eradicated 1980 ⭐
Chickenpox → 90% secondary attack rate ⭐
Measles → Koplik spots ⭐
Rubella → CRS + teratogenic ⭐
Mumps → meningitis + orchitis ⭐
Influenza → shift = pandemic ⭐
H1N1 → 2009 pandemic ⭐
Avian flu → H5N1 zoonotic ⭐
Get the full PDF version of this chapter.